The Scientific and Research Team at Modifi Bio focuses on the development and advancement of novel cancer therapeutics through direct DNA modification. Comprising experts in medicinal chemistry, pharmacology, drug discovery, radiation oncology, and neuro-oncology, this team collaborates to conduct cutting-edge research and translate experimental findings into innovative treatments, particularly targeting brain tumors.
Bruce Ruggeri
Vice President, Pharmacology
Jann Sarkaria
Professor, Radiation Oncology
Kate Cushing Profess...
Yale Brain Tumor Center Co-dir...
Kirk Tanner
Chief Scientific Officer
Kyle Tarantino
Director - Medicinal Chemistry
Milton Harris
’29 Professor
Nate Fishkin
Svp, Drug Discovery And Early ...
Patricia Lorusso
Associate Director For Experim...
Roger Stupp
Chief, Neuro-oncology
Vishwas Paralkar
Member Scientific Advisory Boa...
View all